In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein
about
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexesDetermination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.Separable mechanisms of attachment and cell uptake during retrovirus infection.Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry.Blockade of type I interferon (IFN) production by retroviral replicating vectors and reduced tumor cell responses to IFN likely contribute to tumor selectivityRelationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirusHuman immunodeficiency virus type 1-derived lentivirus vectors pseudotyped with envelope glycoproteins derived from Ross River virus and Semliki Forest virusA small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectorsMurine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system.Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virusLentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes
P2860
Q24673768-1F9DD2C1-423B-40A8-B86C-2B28D28AC14FQ30921356-D2CEB016-E983-4D3E-9ECC-4D4776DCC82EQ33787363-EA666F61-061C-4F0E-BBCD-801D79EBFF6EQ33799437-4B7F4A3A-C6AB-45BB-A218-9316147356BFQ34059493-7A5B6A7B-F2E6-4B85-98B7-E1A8E2B697CFQ34347594-191DCCF4-899E-4CD8-9BDF-1072F214C27AQ35239213-CA68343E-39F6-4167-9F9E-14461E2A794EQ35543170-A5476C76-BD34-4E6A-B57E-96CF29D2DBA6Q39369916-B7200C7E-C4FB-4407-A088-3D197ED4F066Q39685992-801DE030-353F-4889-B659-D51886C895AEQ42169591-3059A121-ACF7-4CE9-BC7C-67ACB389759DQ58796850-FEBD168D-D731-477E-9BDD-E13FF1727236
P2860
In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
In vitro cell-free conversion ...... s surrogate envelope G protein
@ast
In vitro cell-free conversion ...... s surrogate envelope G protein
@en
type
label
In vitro cell-free conversion ...... s surrogate envelope G protein
@ast
In vitro cell-free conversion ...... s surrogate envelope G protein
@en
prefLabel
In vitro cell-free conversion ...... s surrogate envelope G protein
@ast
In vitro cell-free conversion ...... s surrogate envelope G protein
@en
P2093
P2860
P1433
P1476
In vitro cell-free conversion ...... s surrogate envelope G protein
@en
P2093
P2860
P304
P577
1998-08-01T00:00:00Z